Pay in 4 interest-free payments of $6.97 Learn more
Ships within 48 hours · Estimated delivery Sep 5 - Sep 10
There is a strong interest in developing obesity treatments based on glucagon-like peptide-1 (GLP-1) agonists, which have proved to limit morbidity and mortality in type 2 diabetes
But for the average consumer buying insurance through the marketplace or a small employer, the coverage simply vanished
Mounjaro (tirzepatide): Approved for type 2 diabetes
Pharmacology 95 , 7886 (2015)
Heres a clear breakdown of its costing
US$ 29.97
US$ 20.07
US$ 27.40
US$ 29.74
US$ 29.12
US$ 24.99
US$ 21.32
US$ 29.40
US$ 22.52
US$ 29.32
US$ 23.25
US$ 23.03
US$ 28.56
